FY2025 Earnings Forecast for STOK Issued By Chardan Capital
Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) – Equities researchers at Chardan Capital issued their FY2025 earnings per share estimates for shares of Stoke Therapeutics in a research note issued to investors on Monday, March 24th. Chardan Capital analyst R. Li expects that the company will post earnings of ($1.75) per share for the year. […]
Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) – Equities researchers at Chardan Capital issued their FY2025 earnings per share estimates for shares of Stoke Therapeutics in a research note issued to investors on Monday, March 24th. Chardan Capital analyst R. Li expects that the company will post earnings of ($1.75) per share for the year. […]
